Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endometrial Cancer, Endometrial Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00002764
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerMetastatic Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 340
Early research (Phase 1)Not Yet RecruitingNCT07807345
What this trial is testing

Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic

Who this might be right for
Head & Neck Squamous Cell CarcinomaNon-Small Cell Lung CancerEsophageal Cancer+5 more
Sutro Biopharma, Inc. 285
Not applicableLooking for participantsNCT07124000
What this trial is testing

DESTINY-PANTUMOUR04

Who this might be right for
Adenocarcinoma (NOS)Anal CancerBladder Cancer+24 more
AstraZeneca 100
Testing effectiveness (Phase 2)UnknownNCT01770171
What this trial is testing

Carboplatin-Paclitaxel ± Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial Cancer

Who this might be right for
Stage III-IV or Recurrent Endometrial Cancer
Catholic University of the Sacred Heart 108
Early research (Phase 1)Ended earlyNCT05229900
What this trial is testing

SGN-ALPV in Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsCarcinoma, Non-Small-Cell Lung+4 more
Seagen Inc. 43
Large-scale testing (Phase 3)Ended earlyNCT00566644
What this trial is testing

Intrauterine Levonorgestrel and Observation or Observation Alone in Preventing Atypical Endometrial Hyperplasia and Endometrial Cancer in Women With Hereditary Non-Polyposis Colorectal Cancer or Lynch Syndrome

Who this might be right for
Endometrial CancerHereditary Non-polyposis Colon Cancer (hmsh2, hmlh1, hpms1, hpms2)
St George's, University of London 600
Testing effectiveness (Phase 2)Study completedNCT00739830
What this trial is testing

Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6)

Who this might be right for
Endometrial Cancer
Merck Sharp & Dohme LLC 130
Testing effectiveness (Phase 2)Looking for participantsNCT01174121
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

Who this might be right for
Metastatic Colorectal CancerMetastatic Pancreatic CancerMetastatic Ovarian Cancer+2 more
National Cancer Institute (NCI) 332
Early research (Phase 1)Ended earlyNCT05827614
What this trial is testing

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

Who this might be right for
Triple Negative Breast Cancer (TNBC)High Grade Serous Ovarian CarcinomaHigh Grade Endometrial Carcinoma+9 more
Boundless Bio, Inc. 85
Testing effectiveness (Phase 2)Active Not RecruitingNCT06129604
What this trial is testing

Pilot Window of Opportunity Trial (POET)

Who this might be right for
Colorectal Carcinoma (CRC)Endometrial Carcinoma (EC)
University of Oklahoma 10
Not applicableStudy completedNCT03171506
What this trial is testing

Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient Modification

Who this might be right for
Ovarian CancerEndometrial Cancer
University of Alabama at Birmingham 57
Not applicableStudy completedNCT05378152
What this trial is testing

Assessing the Benefit of Pipelle Biopsy in Patients With Postmenopausal Bleeding and an Atrophic-appearing Cavity

Who this might be right for
Postmenopausal BleedingEndometrial CancerEndometrial Hyperplasia
Royal College of Surgeons, Ireland 82
Testing effectiveness (Phase 2)Active Not RecruitingNCT01686126
What this trial is testing

Improving the Treatment for Women With Early Stage Cancer of the Uterus

Who this might be right for
Complex Endometrial Hyperplasia With AtypiaGrade 1 Endometrial Endometrioid Adenocarcinoma
Queensland Centre for Gynaecological Cancer 165
Not applicableUnknownNCT02820506
What this trial is testing

Sentinel Node Mapping in Women With Endometrial and Cervical Cancer

Who this might be right for
Uterine Cervical NeoplasmsUterine Neoplasms
University of Southern Denmark 300
Early research (Phase 1)Study completedNCT01440998
What this trial is testing

Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mucinous Adenocarcinoma+13 more
National Cancer Institute (NCI) 18
Not applicableUnknownNCT01187706
What this trial is testing

A Controlled Study of Quality of Life and it's Related Factors Among Gynecological Cancer Survivors

Who this might be right for
Cervical CancerOvarian CancerEndometrial Cancer
National Taiwan University Hospital 140
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07605247
What this trial is testing

Tirzepatide in the Treatment of Endometrial Cancer

Who this might be right for
Endometrial Cancer
Rutgers, The State University of New Jersey 30
Not applicableUnknownNCT03931265
What this trial is testing

Ketohexokinase Isoforms in Endometrial Cancer.

Who this might be right for
Endometrial Cancer
Far Eastern Memorial Hospital 220
Testing effectiveness (Phase 2)Ended earlyNCT03077698
What this trial is testing

An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Xenetic Biosciences, Inc. 25
Testing effectiveness (Phase 2)UnknownNCT02052128
What this trial is testing

Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers

Who this might be right for
Progesterone Receptor Positive Tumor: Max 1 Line of Prior Chemotherapy, no Prior Hormone Therapy
Arno Therapeutics 60
Next Page